As of September 30, 2025, Aspermont Limited carries a market capitalization of 10.12M, placing it among publicly traded companies globally. Its enterprise value stands at 10.12M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 10.12M |
| Enterprise Value | 10.12M |
Aspermont Limited's next confirmed earnings release is scheduled for November 27, 2026.
| Earnings Date | 11/27/2026 |
As of September 30, 2025, Aspermont Limited has 11.56M shares outstanding.
| Shares Outstanding | 11.56M |
These figures are as of September 30, 2025.
| PS Ratio | 0.76 |
These figures are as of September 30, 2025. The EV/Sales ratio of 0.88 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 10.12M versus a market cap of 10.12M, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 0.88 |
These figures are as of September 30, 2025.
| Interest Coverage | -41.57 |
Over the twelve months ended September 30, 2025, Aspermont Limited recorded an income tax benefit of -81,700.95 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -2.25M and -1.96M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | -81,700.95 |
As of the close on October 23, 2026, Aspermont Limited's stock has gained approximately 17.33% over the past 52 weeks. The 50-day moving average sits at 0.79, while the 200-day moving average is 1.04.
| 52-Week Price Change | 17.33% |
| 50-Day Moving Average | 0.79 |
| 200-Day Moving Average | 1.04 |
Over the twelve months ended September 30, 2025, Aspermont Limited generated 11.52M in revenue and converted that into -1.96M in net income, yielding earnings per share of -0.22. EBITDA reached -2.27M, while operating income came in at -3.07M.
| Revenue | 11.52M |
| Gross Profit | 5.23M |
| Operating Income | -3.07M |
| Pretax Income | -2.25M |
| Net Income | -1.96M |
| EBITDA | -2.27M |
| EBIT | -3.07M |
| Earnings Per Share (EPS) | -0.22 |
These figures cover the twelve months ended September 30, 2025.
| Capital Expenditures | -744,323.79 |
Over the twelve months ended September 30, 2025, Aspermont Limited posted a gross margin of 45.43, reflecting its pricing power and cost economics. The operating margin of -26.61 and net profit margin of -17.04 provide insight into operational efficiency.
| Gross Margin | 45.43 |
| Operating Margin | -26.61 |
| Pretax Margin | -19.55 |
| Profit Margin | -17.04 |
| EBITDA Margin | -19.72 |
These figures cover the twelve months ended September 30, 2025. Total shareholder yield is negative at -11.29, meaning Aspermont Limited raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -11.29 |
Aspermont Limited's most recent stock split took place on March 17, 2026 with a 250:1 split ratio.
| Last Split Date | 3/17/2026 |
| Split Ratio | 250:1 |
Already premium?